REGENXBIO is a longtime player in the gene therapy space, but one that’s yet to bring its own therapy to market (in the early ...
JPMorgan Chase, the country’s biggest bank, is following through on its return to work mandate. Many of the bank’s more than ...
Keefe, Bruyette & Woods analyst Kyle Voigt increased the price target for LPL Financial Holdings (NASDAQ:LPLA) to $405 from the previous target of $390, while reaffirming an Outperform rating on the ...
Wall Street analysts appeared to breathe a sigh of relief after Apple's first quarter earnings modestly beat analysts’ forecasts and the company’s explanation of falling iPhone sales in China eased ...